A new 3D-structure of a cancer-linked protein — BRD4 — bound to its cellular partner reveals details of how the protein binds to chromosomes and could offer insights for future disease treatments.

A study from the Dartmouth Cancer Center, led by James B. Yu, MD, MHS, reveals that more men in the U.S. are being diagnosed with advanced and aggressive forms of prostate cancer. Analyzing nearly two decades of data, the study highlights trends such as rising prostate-specific antigen (PSA) levels, an increase in high-grade tumors from 2008 to 2015, a steady rise in cases of metastatic prostate cancer since 2007, and growth in higher-risk genetic features of tumors.

St. Jude Children's Research Hospital is the third best children's hospital in the U.S., according to U.S. News & World Report

BUFFALO, NY — September 15, 2026 — A new research paper was published in Volume 13 of Oncoscience on August 19, 2026, titled “Validation and psychometric properties of the Cancer Stigma Scale (CASS) in the Greek population.”

The biologic drug interferon-alpha can benefit patients with blood cancers called myeloproliferative neoplasms by forcing mutant blood stem cells to become shorter-lived white blood cells, according to a study by Weill Cornell Medicine investigators. Because the broad activity of interferon-alpha can induce significant side effects, developing new focused strategies based on these mechanistic findings could meet an important need in cancer therapy.